Octarine Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $11M

  • Investors
  • 16

Octarine Bio General Information

Description

Manufacturer of bio-based colorants designed for textiles, plastics, and packaging. The company utilizes a synthetic biology platform to produce colorants for drop-in integration, providing material manufacturers with bio-based dyes, plastic colorants, and packaging dyes that achieve price parity with conventional alternatives, enabling sustainable material transformation without compromising on cost or scalability.

Contact Information

Website
www.octarinebio.com
Formerly Known As
Octarine IVS
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lersø Parkallé 42, 1-th
  • 2100 Copenhagen
  • Denmark
Primary Industry
Specialty Chemicals
Other Industries
Biotechnology
Vertical(s)
Advanced Manufacturing, CleanTech, LOHAS & Wellness, Climate Tech, Life Sciences
Corporate Office
  • Lersø Parkallé 42, 1-th
  • 2100 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Octarine Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 22-Jan-2026 $11M Completed Clinical Trials - Phase 2
7. Early Stage VC 21-Sep-2022 Completed Clinical Trials - Phase 2
6. Early Stage VC (Series A) 11-Mar-2021 Completed Clinical Trials - Phase 2
5. Accelerator/Incubator 01-Jan-2021 Completed Clinical Trials - Phase 2
4. Early Stage VC 10-Jan-2020 Completed Startup
3. Seed Round 01-Jan-2020 Completed Startup
2. Accelerator/Incubator 29-May-2019 Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Octarine Bio’s complete valuation and funding history, request access »

Octarine Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 7,201 $116.14 $116.14 1x $116.14 6.52%
Ordinary 2,386 $96.79 $96.79 1x $96.79 2.16%
To view Octarine Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Octarine Bio Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

Octarine Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4594515-A2 Genetically modified host cells producing violacein, analogues, and derivatives thereof Pending 26-Sep-2022
US-20260092179-A1 Genetically modified host cells producing violacein, analogues, and derivatives thereof Pending 26-Sep-2022
WO-2024068434-A2 Genetically modified host cells producing violacein, analogues, and derivatives thereof Inactive 26-Sep-2022
WO-2024068434-A3 Genetically modified host cells producing violacein, analogues, and derivatives thereof Inactive 26-Sep-2022
EP-4347856-A2 Methods for producing tryptamine derivatives Pending 27-May-2021 C12P19/44
To view Octarine Bio’s complete patent history, request access »

Octarine Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Octarine Bio Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
DSM-Firmenich Corporation Minority
Edaphon Impact Investing Minority
Angel (individual) Minority
Angel (individual) Minority
The Footprint Firm Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Octarine Bio FAQs

  • When was Octarine Bio founded?

    Octarine Bio was founded in 2018.

  • Where is Octarine Bio headquartered?

    Octarine Bio is headquartered in Copenhagen, Denmark.

  • What is the size of Octarine Bio?

    Octarine Bio has 14 total employees.

  • What industry is Octarine Bio in?

    Octarine Bio’s primary industry is Specialty Chemicals.

  • Is Octarine Bio a private or public company?

    Octarine Bio is a Private company.

  • What is the current valuation of Octarine Bio?

    The current valuation of Octarine Bio is .

  • What is Octarine Bio’s current revenue?

    The current revenue for Octarine Bio is .

  • How much funding has Octarine Bio raised over time?

    Octarine Bio has raised $16.8M.

  • Who are Octarine Bio’s investors?

    DSM-Firmenich, Edaphon, , , and The Footprint Firm are 5 of 16 investors who have invested in Octarine Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process